Page last updated: 2024-11-03

risperidone and Porphyrias

risperidone has been researched along with Porphyrias in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santos, M1
Madhusoodanan, S1
Kaur, K1
Brenner, R1

Reviews

1 review available for risperidone and Porphyrias

ArticleYear
Psychiatric symptoms associated with porphyria: A case report and brief review.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2017, Volume: 29, Issue:3

    Topics: Adult; Antipsychotic Agents; Hispanic or Latino; Humans; Male; Paliperidone Palmitate; Porphyrias; P

2017